ReviewInternational journal of general medicine2026
Traditional Chinese Medicine in Hyperuricemia: Current Advances, Mechanistic Insights, and Clinical Challenges.
Review in International journal of general medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The global prevalence of hyperuricemia is steadily increasing. This narrative review systematically summarizes the epidemiological characteristics, pathophysiological mechanisms and mainstream diagnostic approaches of hyperuricemia, with a focus on the theoretical basis, pharmacological mechanisms and clinical applications of Traditional Chinese Medicine (TCM) for its intervention. Accumulated studies have demonstrated that TCM can regulate serum uric acid (SUA) levels via multiple pathways, including inhibiting key enzymes involved in uric acid synthesis such as xanthine oxidase, modulating urate transporters, relieving inflammatory responses and regulating gut microbiota. Classic herbal formulas including Simiao San and Fangji Huangqi Tang can effectively reduce SUA levels and alleviate comorbidities associated with hyperuricemia. As a narrative review, this paper objectively analyzes the existing limitations in relevant research, such as inadequate sample sizes, potential bias, over-reliance on animal experiments and insufficient safety evaluations. It also discusses the advantages, disadvantages and controversies concerning combined TCM therapies. Furthermore, future research directions are proposed, covering clinical evidence grading, standardization of herbal preparations, precision diagnosis and treatment, as well as new drug development. This review aims to provide evidence-based references and innovative ideas for the comprehensive prevention and management of hyperuricemia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.